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Finding the balance in complex regional
pain syndrome
Expertise, optimism, and evidence
Complex regional pain syndrome (CRPS), perhaps
more than any other chronic pain disorder, is perplex-
ing. It is highly disabling, particularly once it has “set
in,” and it has a tendency to polarize the community
—some view it as a quasidiagnosis to obscure malin-
gering or conceal substandard clinical skills,1 and
others as a multiple system overprotective response.2
What is agreed is that its pathophysiology is not com-
pletely understood and that it is difficult to treat. In
light of this rather murky backdrop, we welcome the
new perspectives article in this issue of Neurology® by
Birklein et al.3 They describe their own clinical
approach to the problem and their impressions of
what works, what does not, and where the field might
be heading. The lead author is the most prolific and
arguably the most important researcher in this field,
and the article clearly draws on a wealth of expertise
and clinical experience probably unmatched globally.
The article reminds us of the remaining substantial
challenges that we face: for example, the need for
prospective studies, higher quality clinical trials and
audits, and a putative model that accounts for the
transition from acute CRPS to chronic CRPS, which
is arguably characterized by distinct pathophysiology.
Anyone who treats a good number of CRPS patients
will recognize the clinical patterns to which the au-
thors allude and be comforted by the realization that
even this group, at the top of the field, share the same
substantial treatment challenges.
It is critical, however, to position the article clearly
as a perspectives piece, rather than a review of the
available literature. Failure to recognize this might
lead the naive reader to conclude that the evidence
is more certain than it actually is. A case in point is
the authors’ account of cortical reorganization in
CRPS. The authors declare that, particularly in the
chronic stage, signs and symptoms result from cortical
reorganization. This is intuitively attractive and we
are among those who have developed treatments on
the basis of this possibility,4 but it is a causal inference
for which, to our knowledge, there are still no solid
supportive data. In fact, one might equally declare
that signs and symptoms cause the cortical reorgani-
zation. Perhaps both are correct. Or neither. The
point is that the risk presented by such declarative
statements is that they become embedded in popular
clinical consciousness, from whence they are difficult
to extract should evidence against them emerge. Rel-
evant here is a recent meta-analysis that highlighted the
paucity and fragility of the evidence underpinning the
popular view that the sensory cortical representation of
the CRPS-affected limb shrinks,5 a view well
ensconced in the clinical and research community.
At the risk of sounding prudish, a measured
approach is also important when considering treat-
ments. Systematic review of the evidence shows that,
of the few treatments to have shown promise, the qual-
ity of the evidence actually remains low.6 Rehabilita-
tion therapies vary widely and while some approaches
show some promise, others show only small improve-
ments6,7; sympathetic block evidence is essentially neg-
ative,8 spinal cord stimulators are promising, although
there are no sham-controlled studies, and the adverse
event rate appears high.9 One might contend that the
authors’ advice that avoiding pain is deleterious seems
sensible but, again, is based on clinical observations by
the authors rather than published data. Finally, we
agree that pain exposure therapy is promising but we
await the results of the first clinical trial comparing this
to conventional treatment. Such tensions remind us all
of the need to balance innovation and evidence, prom-
ise and providence. Birklein et al. point out the poten-
tially large disconnect that exists between the treatment
effects observed in clinical trials and those observed in
clinical practice. Herein lies the potential value of inde-
pendently conducted high-quality clinical outcome
audits and extensive collaborations using a core dataset,
as is being pursued by the CRPS Special Interest
Group of the International Association for the Study
of Pain, although the case remains that clinical trials
remain the best tool with which to estimate the true
effects of our various treatments.
We recommend the reader to Birklein et al.’s open
account of their own perspectives and experiences
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dealing with CRPS. It is an important addition to the
field and to have laid out their practices for all to
critique is both generous and courageous. We also
recommend that readers consult the Cochrane review
on CRPS treatments6 and the available clinical guide-
lines (e.g., references 10 and 11).
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